Streptococcus rapid test - Import export

Screen Test Streptococcus A is a rapid test for self-diagnostic use for the qualitative detection of group A streptococcus antigen from pharyngeal swab specimens to aid in the early diagnosis of group A Streptococcus infection. The package contains 2 Strep A tests. Screen Check Test Streptococcus A is an in vitro diagnostic medical device CE 0123. Read the warnings and operating instructions carefully. Authorization of 7/04/2021.

Screen Test Streptococcus A is a rapid test for self-diagnostic use for the qualitative detection of group A streptococcus antigen from pharyngeal swab specimens to aid in the early diagnosis of group A Streptococcus infection. Screen Check Test Streptococcus A is an in vitro diagnostic medical device CE 0123. Read the warnings and operating instructions carefully. Authorization of 7/04/2021. Benefits Streptococcus A detection Rapid result for streptococcal A antigen

Streptococcus A Rapid Test – Product code: SC-0715-20 Immunoassay well on single-phase membrane for the rapid and qualitative determination of group A streptococcal antigens directly from the throat swab, also present in the package the positive and negative control. The Strep A rapid test is a rapid immunochromatographic test for the qualitative detection of Strep A antigens in throat swab specimens to aid in the diagnosis of Group A Streptococcal infections. The Strep A rapid test is a rapid test that qualitatively detects the presence of Strep A antigens in throat swab specimens, giving results within 5 minutes. The test uses Lancefield Group A Strep A whole cell specific antibodies to selectively detect Strep A antigens in a throat swab specimen.

The SARS-CoV-2 (COVID-19) Antigen Rapid Test (Saliva) is a single-use test intended to detect in human saliva the novel coronavirus SARS-CoV-2 that causes COVID-19. This test is designed for home use with saliva samples collected independently from symptomatic individuals suspected of being infected with SARS-CoV-2. With the rapid SARS-CoV-2 (COVID-19) antigen test (Saliva), only a preliminary result is obtained; final confirmation should be based on the results of clinical diagnosis. Result in 15 minutes. Screen Check Test Covid-19 Saliva is an in vitro diagnostic medical device CE 1434. Read the warnings and instructions for use carefully.

The Clostridium difficile Toxin A + Toxin B combination rapid test (Feces) is a rapid chromatographic immunoassay for the qualitative detection of Toxin A and Toxin B Clostridium difficile antigens in human stool samples. The Clostridium difficile Toxin A + Toxin B Combination Rapid Test detects two distinct antigens in stool samples for C. difficile, viz., Toxin A and Toxin B on two different test strips in the same device, thus simultaneously detects two specific Clostridium antigens hard. Clostridium difficile is an anaerobic bacterium that acts as an opportunistic pathogen: it grows in the intestine when the normal flora is altered by antibiotic therapy. Toxigenic strains of Clostridium difficile cause infections from simple diarrhea to pseudomembranous colitis, which can even cause death. The disease is caused by two toxins produced by the toxigenic strains of C. difficile: